Like and comment_老虎社区_美港股上老虎

2021-09-14

Like and comment

Busy IPO market this week poised to make 2021 the biggest year ever by proceeds<blockquote>本周繁忙的 IPO 市场有望使 2021 年成为有史以来收益最大的一年</blockquote>

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":886457179,"tweetId":"886457179","gmtCreate":1631620028791,"gmtModify":1631891282761,"author":{"id":3581714447881138,"idStr":"3581714447881138","authorId":3581714447881138,"authorIdStr":"3581714447881138","name":"nuxezt","avatar":"https://static.tigerbbs.com/59377d9d4868bc55b936ae5d44ea9d14","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":11,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","extraTitle":"","html":"<html><head></head><body>Like and comment&nbsp;</body></html>","htmlText":"<html><head></head><body>Like and comment&nbsp;</body></html>","text":"Like and comment","highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/886457179","repostId":1160275332,"repostType":4,"repost":{"id":"1160275332","kind":"news","pubTimestamp":1631604098,"share":"https://www.laohunote.com/m/news/1160275332?lang=zh_CN&edition=full","pubTime":"2021-09-14 15:21","market":"us","language":"en","title":"Busy IPO market this week poised to make 2021 the biggest year ever by proceeds<blockquote>本周繁忙的 IPO 市场有望使 2021 年成为有史以来收益最大的一年</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1160275332","media":"MarketWatch","summary":"Swiss running-shoe company backed by Roger Federer and drive-through coffee chain expected to hit th","content":"Swiss running-shoe company backed by Roger Federer and drive-through coffee chain expected to hit the market this week <blockquote>由罗杰·费德勒和得来速咖啡连锁店支持的瑞士跑鞋公司预计将于本周上市</blockquote> <img src=\"https://static.tigerbbs.com/18111af5f5bda21b3128860fe616c5ca\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\">Swiss tennis giant Roger Federer is a backer of one of this week's bigger IPOs.<blockquote>瑞士网球巨人罗杰·费德勒是本周最大的IPO之一的支持者。</blockquote> After a flurry of initial-public-offering launches last week&nbsp;set the market up for a busy fall for deals, 11 are expected to price this week and raise more than $3 billion in proceeds. <blockquote>在上周一系列首次公开募股启动让市场陷入繁忙的交易量下跌之后，预计本周将有 11 家公司定价并筹集超过 30 亿美元的收益。</blockquote> If all deals materialize, it will make 2021 the biggest year for IPO proceeds ever, and shatter the previous record by about 30%, according to Bill Smith, founder and chief executive of Renaissance Capital, a provider of institutional research and exchange-traded funds oriented around IPOs. The market is expected to see some 375 deals for the year, raising $125 billion, according to Renaissance, beating the $97 billion raised in 2000 during the dot-com boom. <blockquote>机构研究和交易所交易基金提供商 Renaissance Capital 的创始人兼首席执行官比尔·史密斯 (Bill Smith) 表示，如果所有交易都能实现，2021 年将成为有史以来 IPO 收益最大的一年，并打破之前的记录约 30%。据 Renaissance 称，今年市场预计将达成约 375 笔交易，筹集 1250 亿美元，超过 2000 年互联网繁荣时期筹集的 970 亿美元。</blockquote> “After the long summer break, this week is a litmus test for upcoming tech, biotech, and consumer IPOs,” Smith wrote in a market commentary. The list includes a Swiss running-shoe company backed by tennis giant Roger Federer, a drive-through coffee kiosk operator and a mortgage insurer that was spun out of insurer Genworth Financial. <blockquote>“史密斯在一篇市场评论中写道：”在漫长的暑假之后，本周是即将到来的科技、生物技术和消费品 IPO 的试金石。这份名单包括一家由网球巨头罗杰·费德勒支持的瑞士跑鞋公司、一家免下车咖啡亭运营商以及一家从保险公司 Genworth Financial 分拆出来的抵押贷款保险公司。</blockquote> The biggest deal of the week is expected to come from Thoughtworks,a Chicago-based technology consultancy that will go public at a valuation of up to $6.1 billion.<blockquote>本周最大的交易预计将来自总部位于芝加哥的技术咨询公司 Thoughtworks，该公司将以高达 61 亿美元的估值上市。</blockquote> The company, which expects to change its name from Turing Holding Corp. to Thoughtworks with completion of the IPO, said a total of 36.84 million shares will be offered, split between the company and selling shareholders.<blockquote>该公司预计在 IPO 完成后将名称从 Turing Holding Corp. 更名为 Thoughtworks，并表示将发行总计 3684 万股股票，分配给公司和出售股东。</blockquote> The deal is expected to price at between $18 and $20 a share, and the stock will trade on the Nasdaq under the ticker symbol “TWKS.” Goldman Sachs and JPMorgan are the lead underwriters. The company recorded net income of $79.3 million on revenue of $803.4 million in 2020, after income of $28.4 million on revenue of $772.2 million in 2019.<blockquote>预计交易价格将在每股 18 美元至 20 美元之间，股票将在纳斯达克交易，股票代码为 “TWKS”。高盛和摩根大通是主承销商。该公司 2020 年收入为 8.034 亿美元，净利润为 7930 万美元，而 2019 年收入为 7.722 亿美元，净利润为 2840 万美元。</blockquote> The Swiss athletic-footwear maker On Holding&nbsp;is expected to raise up to $622 million at a valuation of almost $6 billion. On has applied to list 31.1 million shares priced at $18 to $20 each on the New York Stock Exchange, under the ticker symbol “ONON.”<blockquote>这家持股的瑞士运动鞋制造商预计将以近 60 亿美元的估值筹集高达 6.22 亿美元的资金。On 已申请在纽约证券交易所上市 3110 万股股票，每股定价为 18 至 20 美元，股票代码为 “ONON”。</blockquote> Goldman Sachs, Morgan Stanley and Morgan Stanley are lead underwriters in a syndicate of nine banks on the On deal. Proceeds are to be used for general corporate purposes. The company has a line that it co-developed with Federer.<blockquote>高盛、摩根士丹利和摩根士丹利是这笔交易的九家银行组成的银团的主承销商。所得款项将用于一般公司用途。该公司有一条与费德勒共同开发的产品线。</blockquote> The company had net income of 3.8 million Swiss francs ($4.1 million) in the six months through June 30, after a loss of 33.1 million francs in the year-earlier period,&nbsp;according to its IPO documents.&nbsp;Sales came to 315.5 million francs, up from 170.9 million francs.<blockquote>根据其首次公开募股文件，该公司在截至 6 月 30 日的六个月中净利润为 380 万瑞士法郎（约合 410 万美元），而去年同期亏损 3310 万法郎。销售额从 1.709 亿法郎增至 3.155 亿法郎。</blockquote> Also from Switzerland, sports betting site Sportrader Group AG&nbsp;plans to offer 19 million shares priced at $25 to $28 each, for a valuation of up to $31 billion. The company has applied to list on Nasdaq under the ticker symbol “SRAD.” JPMorgan, Morgan Stanley, Citigroup and UBS are lead underwriters in a syndicate of 13 banks working on the deal.<blockquote>同样来自瑞士的体育博彩网站Sportrader Group AG计划发行1900万股股票，每股定价25至28美元，估值高达310亿美元。该公司已申请在纳斯达克上市，股票代码为 “SRAD”。摩根大通、摩根士丹利、花旗集团和瑞银是参与该交易的 13 家银行财团的主承销商。</blockquote> Proceeds are to be used for working capital and to spur growth. The company had a net profit of $29.9 million in the first six months of the year, on revenue of $321 million,&nbsp;according to its filing documents.<blockquote>所得款项将用作营运资金和刺激增长。根据其备案文件，该公司今年前六个月净利润为 2990 万美元，收入为 3.21 亿美元。</blockquote> Dutch Bros Inc.,an operator of drive-through shops that serve hot and cold drinks mostly in western U.S. states, is planning to offer 21.1 million shares priced at $18 to $20 each in its IPO, valuing the company at up to $3.3 billion.<blockquote>Dutch Bros Inc. 是一家主要在美国西部各州提供冷热饮料的免下车商店运营商，计划在 IPO 中发行 2110 万股股票，每股定价为 18 至 20 美元，公司估值高达 33 亿美元。</blockquote> BofA Securities, JPMorgan and Jefferies are lead underwriters in a syndicate of 13 banks working on the deal. The company has applied to list on the New York Stock Exchange under the ticker symbol “BROS.”<blockquote>美国银行证券、摩根大通和杰富瑞是参与该交易的 13 家银行财团的主承销商。该公司已申请在纽约证券交易所上市，股票代码为 “BROS.</blockquote> Proceeds are to be used to purchase additional Class A shares — the company is planning to have four classes of stock with differing voting rights. The company had a net loss of $13.6 million, or 32 cents a share, in the first six months of the year, narrower than the loss of $16.5 million, or 38 cents a share, posted in the year-earlier period. Revenue fell to $227.9 million from $327.4 million.<blockquote>所得款项将用于购买额外的 A 类股票——该公司计划持有四类具有不同投票权的股票。该公司今年前六个月净亏损 1,360 万美元，即每股亏损 32 美分，低于去年同期公布的 1,650 万美元，即每股亏损 38 美分。收入从 3.274 亿美元降至 2.279 亿美元。</blockquote> Rounding out the list are:<blockquote>最后一个列表是：</blockquote> •&nbsp;Definitive Healthcare Corp.,&nbsp;a Massachusetts-based provider of healthcare commercial intelligence, is planning to offer 15.56 million shares in its PO, which is expected to price between $21 and $24 a share. At that pricing, the company could be valued at up to $3.55 billion.<blockquote>- 总部位于马萨诸塞州的医疗保健商业智能提供商 Definitive Healthcare Corp. 计划在其 PO 中发行 1556 万股股票，预计每股价格在 21 至 24 美元之间。按照这个定价，该公司的估值可能高达 35.5 亿美元。</blockquote> •&nbsp;Enact Holdings Inc., a mortgage insurer owned by Genworth, is planning to offer 13.3 million shares priced at $19 to $20 each. The company would be valued at $3.3 billion at the top of that range. The company said all shares will be sold by Genworth and it will not receive any proceeds. It has applied to list on Nasdaq under the ticker “ACT.” Goldman Sachs and JPMorgan are lead underwriters in a team of nine banks working on the deal.<blockquote>- Genworth 旗下的抵押贷款保险公司 Enact Holdings Inc. 计划发行 1330 万股股票，每股定价为 19 至 20 美元。该公司的估值最高时为 33 亿美元。该公司表示，所有股份将由Genworth出售，不会获得任何收益。该公司已申请在纳斯达克上市，股票代码为 “ACT”。高盛和摩根大通是参与该交易的九家银行团队的主承销商。</blockquote> •&nbsp;ForgeRock<a href=\"https://www.marketwatch.com/investing/stock/FORG?mod=MW_story_quote&amp;mod=article_inline\" target=\"_blank\">,</a>&nbsp;a California-based identity security platform, is looking to raise up to $264 million with an offering of 11 million shares priced between $21 and $24 a share. That pricing would value the company a valuation of up to $1.91 billion.<blockquote>• 假摇滚<a href=\"https://www.marketwatch.com/investing/stock/FORG?mod=MW_story_quote&amp;mod=article_inline\" target=\"_blank\">,</a>总部位于加利福尼亚州的身份安全平台希望通过发行 1100 万股股票来筹集高达 2.64 亿美元的资金，每股价格在 21 美元至 24 美元之间。该定价将使该公司估值高达 19.1 亿美元。</blockquote> The stock is expected to list on the NYSE under the ticker symbol “FORG.” Morgan Stanley and JPMorgan are the lead underwriters. The company recorded a net loss of $41.8 million on revenue of $127.6 million in 2020, after a loss of $36.9 million on revenue of $104.5 million in 2019.<blockquote>该股预计将在纽约证券交易所上市，股票代码为 “FORG ”。摩根士丹利和摩根大通是主承销商。该公司 2020 年收入为 1.276 亿美元，净亏损 4180 万美元，而 2019 年收入为 1.045 亿美元，亏损 3690 万美元。</blockquote> •Dice Therapeutics&nbsp;is expected to raise up to $170 million at a valuation of up to $583 million and list on Nasdaq under the ticker symbol “DICE.” The biotech is developing therapies to treat chronic diseases in the field of immunology.<blockquote>•Dice Therapeutics 预计将以高达 5.83 亿美元的估值筹集高达 1.7 亿美元的资金，并在纳斯达克上市，股票代码为 “DICE ”。生物技术正在开发治疗免疫学领域慢性疾病的疗法。</blockquote> •Surgical robotics developer Procept BioRobotics,is aiming to raise up to $132 million at a valuation of about $1 billion with plans to list on Nasdaq under the ticker symbol “PRCT.” BofA Securities and Goldman Sachs are lead underwriters.<blockquote>•手术机器人开发商 Procept BioRobotics 的目标是以约 10 亿美元的估值筹集至多 1.32 亿美元，计划在纳斯达克上市，股票代码为 “PRCT”。美国银行证券和高盛是主承销商。</blockquote> “We develop, manufacture and sell the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia, or BPH,” the company says in its IPO documents.<blockquote>“该公司在 IPO 文件中表示：”我们开发、制造和销售 AquaBeam 机器人系统，这是一种先进的图像引导手术机器人系统，用于微创泌尿外科手术，最初的重点是治疗良性前列腺增生（BPH）。</blockquote> •Tyra Biosciences is aiming to raise $107.2 million in IPO proceeds at a valuation of $589 million. The biotech’s leading product candidate is a treatment for bladder cancer. It has applied to list on Nasdaq under the symbol “TYRA.”<blockquote>•Tyra Biosciences 的目标是以 5.89 亿美元的估值筹集 1.072 亿美元的 IPO 收益。该生物技术公司的主要候选产品是治疗膀胱癌的药物。它已申请在纳斯达克上市，代码为 “泰拉 ”。</blockquote> •EzFill Holdings, an app-based mobile fueling company in South Florida, is planning to raise $25 million at a valuation of $100 million. The company has applied to list on Nasdaq under the ticker symbol “EZFL.” ThinkEquity is sole underwriter.<blockquote>•EzFill Holdings 是一家位于南佛罗里达州的基于应用程序的移动加油公司，计划以 1 亿美元的估值筹集 2500 万美元。该公司已申请在纳斯达克上市，股票代码为 “EZFL”。ThinkEquity 是独家承销商。</blockquote> The Renaissance IPO ETF&nbsp;has gained 6% to date in 2021, while the S&amp;P 500&nbsp;has advanced 19%.<blockquote>2021 年迄今为止，Renaissance IPO ETF 上涨了 6%，而标普500上涨了 19%。</blockquote>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Busy IPO market this week poised to make 2021 the biggest year ever by proceeds<blockquote>本周繁忙的 IPO 市场有望使 2021 年成为有史以来收益最大的一年</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBusy IPO market this week poised to make 2021 the biggest year ever by proceeds<blockquote>本周繁忙的 IPO 市场有望使 2021 年成为有史以来收益最大的一年</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nMarketWatch2021-09-14 15:21\n\n</h4>\n</header>\n<article>\nSwiss running-shoe company backed by Roger Federer and drive-through coffee chain expected to hit the market this week <blockquote>由罗杰·费德勒和得来速咖啡连锁店支持的瑞士跑鞋公司预计将于本周上市</blockquote> <img src=\"https://static.tigerbbs.com/18111af5f5bda21b3128860fe616c5ca\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\">Swiss tennis giant Roger Federer is a backer of one of this week's bigger IPOs.<blockquote>瑞士网球巨人罗杰·费德勒是本周最大的IPO之一的支持者。</blockquote> After a flurry of initial-public-offering launches last week&nbsp;set the market up for a busy fall for deals, 11 are expected to price this week and raise more than $3 billion in proceeds. <blockquote>在上周一系列首次公开募股启动让市场陷入繁忙的交易量下跌之后，预计本周将有 11 家公司定价并筹集超过 30 亿美元的收益。</blockquote> If all deals materialize, it will make 2021 the biggest year for IPO proceeds ever, and shatter the previous record by about 30%, according to Bill Smith, founder and chief executive of Renaissance Capital, a provider of institutional research and exchange-traded funds oriented around IPOs. The market is expected to see some 375 deals for the year, raising $125 billion, according to Renaissance, beating the $97 billion raised in 2000 during the dot-com boom. <blockquote>机构研究和交易所交易基金提供商 Renaissance Capital 的创始人兼首席执行官比尔·史密斯 (Bill Smith) 表示，如果所有交易都能实现，2021 年将成为有史以来 IPO 收益最大的一年，并打破之前的记录约 30%。据 Renaissance 称，今年市场预计将达成约 375 笔交易，筹集 1250 亿美元，超过 2000 年互联网繁荣时期筹集的 970 亿美元。</blockquote> “After the long summer break, this week is a litmus test for upcoming tech, biotech, and consumer IPOs,” Smith wrote in a market commentary. The list includes a Swiss running-shoe company backed by tennis giant Roger Federer, a drive-through coffee kiosk operator and a mortgage insurer that was spun out of insurer Genworth Financial. <blockquote>“史密斯在一篇市场评论中写道：”在漫长的暑假之后，本周是即将到来的科技、生物技术和消费品 IPO 的试金石。这份名单包括一家由网球巨头罗杰·费德勒支持的瑞士跑鞋公司、一家免下车咖啡亭运营商以及一家从保险公司 Genworth Financial 分拆出来的抵押贷款保险公司。</blockquote> The biggest deal of the week is expected to come from Thoughtworks,a Chicago-based technology consultancy that will go public at a valuation of up to $6.1 billion.<blockquote>本周最大的交易预计将来自总部位于芝加哥的技术咨询公司 Thoughtworks，该公司将以高达 61 亿美元的估值上市。</blockquote> The company, which expects to change its name from Turing Holding Corp. to Thoughtworks with completion of the IPO, said a total of 36.84 million shares will be offered, split between the company and selling shareholders.<blockquote>该公司预计在 IPO 完成后将名称从 Turing Holding Corp. 更名为 Thoughtworks，并表示将发行总计 3684 万股股票，分配给公司和出售股东。</blockquote> The deal is expected to price at between $18 and $20 a share, and the stock will trade on the Nasdaq under the ticker symbol “TWKS.” Goldman Sachs and JPMorgan are the lead underwriters. The company recorded net income of $79.3 million on revenue of $803.4 million in 2020, after income of $28.4 million on revenue of $772.2 million in 2019.<blockquote>预计交易价格将在每股 18 美元至 20 美元之间，股票将在纳斯达克交易，股票代码为 “TWKS”。高盛和摩根大通是主承销商。该公司 2020 年收入为 8.034 亿美元，净利润为 7930 万美元，而 2019 年收入为 7.722 亿美元，净利润为 2840 万美元。</blockquote> The Swiss athletic-footwear maker On Holding&nbsp;is expected to raise up to $622 million at a valuation of almost $6 billion. On has applied to list 31.1 million shares priced at $18 to $20 each on the New York Stock Exchange, under the ticker symbol “ONON.”<blockquote>这家持股的瑞士运动鞋制造商预计将以近 60 亿美元的估值筹集高达 6.22 亿美元的资金。On 已申请在纽约证券交易所上市 3110 万股股票，每股定价为 18 至 20 美元，股票代码为 “ONON”。</blockquote> Goldman Sachs, Morgan Stanley and Morgan Stanley are lead underwriters in a syndicate of nine banks on the On deal. Proceeds are to be used for general corporate purposes. The company has a line that it co-developed with Federer.<blockquote>高盛、摩根士丹利和摩根士丹利是这笔交易的九家银行组成的银团的主承销商。所得款项将用于一般公司用途。该公司有一条与费德勒共同开发的产品线。</blockquote> The company had net income of 3.8 million Swiss francs ($4.1 million) in the six months through June 30, after a loss of 33.1 million francs in the year-earlier period,&nbsp;according to its IPO documents.&nbsp;Sales came to 315.5 million francs, up from 170.9 million francs.<blockquote>根据其首次公开募股文件，该公司在截至 6 月 30 日的六个月中净利润为 380 万瑞士法郎（约合 410 万美元），而去年同期亏损 3310 万法郎。销售额从 1.709 亿法郎增至 3.155 亿法郎。</blockquote> Also from Switzerland, sports betting site Sportrader Group AG&nbsp;plans to offer 19 million shares priced at $25 to $28 each, for a valuation of up to $31 billion. The company has applied to list on Nasdaq under the ticker symbol “SRAD.” JPMorgan, Morgan Stanley, Citigroup and UBS are lead underwriters in a syndicate of 13 banks working on the deal.<blockquote>同样来自瑞士的体育博彩网站Sportrader Group AG计划发行1900万股股票，每股定价25至28美元，估值高达310亿美元。该公司已申请在纳斯达克上市，股票代码为 “SRAD”。摩根大通、摩根士丹利、花旗集团和瑞银是参与该交易的 13 家银行财团的主承销商。</blockquote> Proceeds are to be used for working capital and to spur growth. The company had a net profit of $29.9 million in the first six months of the year, on revenue of $321 million,&nbsp;according to its filing documents.<blockquote>所得款项将用作营运资金和刺激增长。根据其备案文件，该公司今年前六个月净利润为 2990 万美元，收入为 3.21 亿美元。</blockquote> Dutch Bros Inc.,an operator of drive-through shops that serve hot and cold drinks mostly in western U.S. states, is planning to offer 21.1 million shares priced at $18 to $20 each in its IPO, valuing the company at up to $3.3 billion.<blockquote>Dutch Bros Inc. 是一家主要在美国西部各州提供冷热饮料的免下车商店运营商，计划在 IPO 中发行 2110 万股股票，每股定价为 18 至 20 美元，公司估值高达 33 亿美元。</blockquote> BofA Securities, JPMorgan and Jefferies are lead underwriters in a syndicate of 13 banks working on the deal. The company has applied to list on the New York Stock Exchange under the ticker symbol “BROS.”<blockquote>美国银行证券、摩根大通和杰富瑞是参与该交易的 13 家银行财团的主承销商。该公司已申请在纽约证券交易所上市，股票代码为 “BROS.</blockquote> Proceeds are to be used to purchase additional Class A shares — the company is planning to have four classes of stock with differing voting rights. The company had a net loss of $13.6 million, or 32 cents a share, in the first six months of the year, narrower than the loss of $16.5 million, or 38 cents a share, posted in the year-earlier period. Revenue fell to $227.9 million from $327.4 million.<blockquote>所得款项将用于购买额外的 A 类股票——该公司计划持有四类具有不同投票权的股票。该公司今年前六个月净亏损 1,360 万美元，即每股亏损 32 美分，低于去年同期公布的 1,650 万美元，即每股亏损 38 美分。收入从 3.274 亿美元降至 2.279 亿美元。</blockquote> Rounding out the list are:<blockquote>最后一个列表是：</blockquote> •&nbsp;Definitive Healthcare Corp.,&nbsp;a Massachusetts-based provider of healthcare commercial intelligence, is planning to offer 15.56 million shares in its PO, which is expected to price between $21 and $24 a share. At that pricing, the company could be valued at up to $3.55 billion.<blockquote>- 总部位于马萨诸塞州的医疗保健商业智能提供商 Definitive Healthcare Corp. 计划在其 PO 中发行 1556 万股股票，预计每股价格在 21 至 24 美元之间。按照这个定价，该公司的估值可能高达 35.5 亿美元。</blockquote> •&nbsp;Enact Holdings Inc., a mortgage insurer owned by Genworth, is planning to offer 13.3 million shares priced at $19 to $20 each. The company would be valued at $3.3 billion at the top of that range. The company said all shares will be sold by Genworth and it will not receive any proceeds. It has applied to list on Nasdaq under the ticker “ACT.” Goldman Sachs and JPMorgan are lead underwriters in a team of nine banks working on the deal.<blockquote>- Genworth 旗下的抵押贷款保险公司 Enact Holdings Inc. 计划发行 1330 万股股票，每股定价为 19 至 20 美元。该公司的估值最高时为 33 亿美元。该公司表示，所有股份将由Genworth出售，不会获得任何收益。该公司已申请在纳斯达克上市，股票代码为 “ACT”。高盛和摩根大通是参与该交易的九家银行团队的主承销商。</blockquote> •&nbsp;ForgeRock<a href=\"https://www.marketwatch.com/investing/stock/FORG?mod=MW_story_quote&amp;mod=article_inline\" target=\"_blank\">,</a>&nbsp;a California-based identity security platform, is looking to raise up to $264 million with an offering of 11 million shares priced between $21 and $24 a share. That pricing would value the company a valuation of up to $1.91 billion.<blockquote>• 假摇滚<a href=\"https://www.marketwatch.com/investing/stock/FORG?mod=MW_story_quote&amp;mod=article_inline\" target=\"_blank\">,</a>总部位于加利福尼亚州的身份安全平台希望通过发行 1100 万股股票来筹集高达 2.64 亿美元的资金，每股价格在 21 美元至 24 美元之间。该定价将使该公司估值高达 19.1 亿美元。</blockquote> The stock is expected to list on the NYSE under the ticker symbol “FORG.” Morgan Stanley and JPMorgan are the lead underwriters. The company recorded a net loss of $41.8 million on revenue of $127.6 million in 2020, after a loss of $36.9 million on revenue of $104.5 million in 2019.<blockquote>该股预计将在纽约证券交易所上市，股票代码为 “FORG ”。摩根士丹利和摩根大通是主承销商。该公司 2020 年收入为 1.276 亿美元，净亏损 4180 万美元，而 2019 年收入为 1.045 亿美元，亏损 3690 万美元。</blockquote> •Dice Therapeutics&nbsp;is expected to raise up to $170 million at a valuation of up to $583 million and list on Nasdaq under the ticker symbol “DICE.” The biotech is developing therapies to treat chronic diseases in the field of immunology.<blockquote>•Dice Therapeutics 预计将以高达 5.83 亿美元的估值筹集高达 1.7 亿美元的资金，并在纳斯达克上市，股票代码为 “DICE ”。生物技术正在开发治疗免疫学领域慢性疾病的疗法。</blockquote> •Surgical robotics developer Procept BioRobotics,is aiming to raise up to $132 million at a valuation of about $1 billion with plans to list on Nasdaq under the ticker symbol “PRCT.” BofA Securities and Goldman Sachs are lead underwriters.<blockquote>•手术机器人开发商 Procept BioRobotics 的目标是以约 10 亿美元的估值筹集至多 1.32 亿美元，计划在纳斯达克上市，股票代码为 “PRCT”。美国银行证券和高盛是主承销商。</blockquote> “We develop, manufacture and sell the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia, or BPH,” the company says in its IPO documents.<blockquote>“该公司在 IPO 文件中表示：”我们开发、制造和销售 AquaBeam 机器人系统，这是一种先进的图像引导手术机器人系统，用于微创泌尿外科手术，最初的重点是治疗良性前列腺增生（BPH）。</blockquote> •Tyra Biosciences is aiming to raise $107.2 million in IPO proceeds at a valuation of $589 million. The biotech’s leading product candidate is a treatment for bladder cancer. It has applied to list on Nasdaq under the symbol “TYRA.”<blockquote>•Tyra Biosciences 的目标是以 5.89 亿美元的估值筹集 1.072 亿美元的 IPO 收益。该生物技术公司的主要候选产品是治疗膀胱癌的药物。它已申请在纳斯达克上市，代码为 “泰拉 ”。</blockquote> •EzFill Holdings, an app-based mobile fueling company in South Florida, is planning to raise $25 million at a valuation of $100 million. The company has applied to list on Nasdaq under the ticker symbol “EZFL.” ThinkEquity is sole underwriter.<blockquote>•EzFill Holdings 是一家位于南佛罗里达州的基于应用程序的移动加油公司，计划以 1 亿美元的估值筹集 2500 万美元。该公司已申请在纳斯达克上市，股票代码为 “EZFL”。ThinkEquity 是独家承销商。</blockquote> The Renaissance IPO ETF&nbsp;has gained 6% to date in 2021, while the S&amp;P 500&nbsp;has advanced 19%.<blockquote>2021 年迄今为止，Renaissance IPO ETF 上涨了 6%，而标普500上涨了 19%。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.marketwatch.com/story/busy-ipo-market-this-week-may-make-2021-the-biggest-year-for-proceeds-and-break-previous-record-by-30-11631554372?mod=home-page\">MarketWatch</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite","BROS":"Dutch Bros Inc.","ONON":"On Holding AG","PRCT":"PROCEPT BioRobotics","DH":"Definitive Healthcare Corp.","TYRA":"Tyra Biosciences, Inc.",".SPX":"S&P 500 Index","SRAD":"Sportradar Group AG",".DJI":"道琼斯"},"source_url":"https://www.marketwatch.com/story/busy-ipo-market-this-week-may-make-2021-the-biggest-year-for-proceeds-and-break-previous-record-by-30-11631554372?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160275332","content_text":"Swiss running-shoe company backed by Roger Federer and drive-through coffee chain expected to hit the market this week \nSwiss tennis giant Roger Federer is a backer of one of this week's bigger IPOs.\n\n\nAfter a flurry of initial-public-offering launches last week set the market up for a busy fall for deals, 11 are expected to price this week and raise more than $3 billion in proceeds. \n\nIf all deals materialize, it will make 2021 the biggest year for IPO proceeds ever, and shatter the previous record by about 30%, according to Bill Smith, founder and chief executive of Renaissance Capital, a provider of institutional research and exchange-traded funds oriented around IPOs. The market is expected to see some 375 deals for the year, raising $125 billion, according to Renaissance, beating the $97 billion raised in 2000 during the dot-com boom. \n\n“After the long summer break, this week is a litmus test for upcoming tech, biotech, and consumer IPOs,” Smith wrote in a market commentary. The list includes a Swiss running-shoe company backed by tennis giant Roger Federer, a drive-through coffee kiosk operator and a mortgage insurer that was spun out of insurer Genworth Financial. \n\nThe biggest deal of the week is expected to come from Thoughtworks,a Chicago-based technology consultancy that will go public at a valuation of up to $6.1 billion.\nThe company, which expects to change its name from Turing Holding Corp. to Thoughtworks with completion of the IPO, said a total of 36.84 million shares will be offered, split between the company and selling shareholders.\n\nThe deal is expected to price at between $18 and $20 a share, and the stock will trade on the Nasdaq under the ticker symbol “TWKS.” Goldman Sachs and JPMorgan are the lead underwriters. The company recorded net income of $79.3 million on revenue of $803.4 million in 2020, after income of $28.4 million on revenue of $772.2 million in 2019.\nThe Swiss athletic-footwear maker On Holding is expected to raise up to $622 million at a valuation of almost $6 billion. On has applied to list 31.1 million shares priced at $18 to $20 each on the New York Stock Exchange, under the ticker symbol “ONON.”\n\nGoldman Sachs, Morgan Stanley and Morgan Stanley are lead underwriters in a syndicate of nine banks on the On deal. Proceeds are to be used for general corporate purposes. The company has a line that it co-developed with Federer.\n\nThe company had net income of 3.8 million Swiss francs ($4.1 million) in the six months through June 30, after a loss of 33.1 million francs in the year-earlier period, according to its IPO documents. Sales came to 315.5 million francs, up from 170.9 million francs.\n\nAlso from Switzerland, sports betting site Sportrader Group AG plans to offer 19 million shares priced at $25 to $28 each, for a valuation of up to $31 billion. The company has applied to list on Nasdaq under the ticker symbol “SRAD.” JPMorgan, Morgan Stanley, Citigroup and UBS are lead underwriters in a syndicate of 13 banks working on the deal.\n\nProceeds are to be used for working capital and to spur growth. The company had a net profit of $29.9 million in the first six months of the year, on revenue of $321 million, according to its filing documents.\n\nDutch Bros Inc.,an operator of drive-through shops that serve hot and cold drinks mostly in western U.S. states, is planning to offer 21.1 million shares priced at $18 to $20 each in its IPO, valuing the company at up to $3.3 billion.\n\nBofA Securities, JPMorgan and Jefferies are lead underwriters in a syndicate of 13 banks working on the deal. The company has applied to list on the New York Stock Exchange under the ticker symbol “BROS.”\nProceeds are to be used to purchase additional Class A shares — the company is planning to have four classes of stock with differing voting rights. The company had a net loss of $13.6 million, or 32 cents a share, in the first six months of the year, narrower than the loss of $16.5 million, or 38 cents a share, posted in the year-earlier period. Revenue fell to $227.9 million from $327.4 million.\n\nRounding out the list are:\n• Definitive Healthcare Corp., a Massachusetts-based provider of healthcare commercial intelligence, is planning to offer 15.56 million shares in its PO, which is expected to price between $21 and $24 a share. At that pricing, the company could be valued at up to $3.55 billion.\n• Enact Holdings Inc., a mortgage insurer owned by Genworth, is planning to offer 13.3 million shares priced at $19 to $20 each. The company would be valued at $3.3 billion at the top of that range. The company said all shares will be sold by Genworth and it will not receive any proceeds. It has applied to list on Nasdaq under the ticker “ACT.” Goldman Sachs and JPMorgan are lead underwriters in a team of nine banks working on the deal.\n• ForgeRock, a California-based identity security platform, is looking to raise up to $264 million with an offering of 11 million shares priced between $21 and $24 a share. That pricing would value the company a valuation of up to $1.91 billion.\nThe stock is expected to list on the NYSE under the ticker symbol “FORG.” Morgan Stanley and JPMorgan are the lead underwriters. The company recorded a net loss of $41.8 million on revenue of $127.6 million in 2020, after a loss of $36.9 million on revenue of $104.5 million in 2019.\n•Dice Therapeutics is expected to raise up to $170 million at a valuation of up to $583 million and list on Nasdaq under the ticker symbol “DICE.” The biotech is developing therapies to treat chronic diseases in the field of immunology.\n•Surgical robotics developer Procept BioRobotics,is aiming to raise up to $132 million at a valuation of about $1 billion with plans to list on Nasdaq under the ticker symbol “PRCT.” BofA Securities and Goldman Sachs are lead underwriters.\n“We develop, manufacture and sell the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia, or BPH,” the company says in its IPO documents.\n•Tyra Biosciences is aiming to raise $107.2 million in IPO proceeds at a valuation of $589 million. The biotech’s leading product candidate is a treatment for bladder cancer. It has applied to list on Nasdaq under the symbol “TYRA.”\n•EzFill Holdings, an app-based mobile fueling company in South Florida, is planning to raise $25 million at a valuation of $100 million. The company has applied to list on Nasdaq under the ticker symbol “EZFL.” ThinkEquity is sole underwriter.\nThe Renaissance IPO ETF has gained 6% to date in 2021, while the S&P 500 has advanced 19%.","news_type":1,"symbols_score_info":{"ONON":0.9,".DJI":0.9,"TYRA":0.9,".IXIC":0.9,"BROS":0.9,"ACT.UK":0.9,"PRCT":0.9,"TWKS":0.9,".SPX":0.9,"DRNA":0.9,"FORG":0.9,"DH":0.9,"SRAD":0.9}},"isVote":1,"tweetType":1,"viewCount":2566,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":14,"subscribersOnly":false,"subscribersOnlyAccessible":false,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/886457179"}